Cancer discovery involves identifying new biomarkers, genetic mutations, and cellular pathways that contribute to the onset and progression of cancer. This phase is crucial for understanding the underlying mechanisms of cancer and for the development of targeted therapies. Often, discovery research begins with identifying potential oncogenes and tumor suppressor genes through genomic studies, such as next-generation sequencing.
